Zobrazeno 1 - 10
of 358
pro vyhledávání: '"Hayato TADA"'
Autor:
Kenichi Nakajima, Tomoaki Nakata, Takahiro Doi, Derk O. Verschure, Viviana Frantellizzi, Maria Silvia De Feo, Hayato Tada, Hein J. Verberne
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Background 123I-meta-iodobenzylguanidine (mIBG) has been applied to patients with chronic heart failure (CHF). However, the relationship between 123I-mIBG activity and lethal arrhythmic events (ArE) is not well defined. This study aimed to d
Externí odkaz:
https://doaj.org/article/1de012c44a2249698c292a75aeabd799
Publikováno v:
JACC: Case Reports, Vol 29, Iss 12, Pp 102367- (2024)
We present a young boy with a diagnosis of homozygous familial hypercholesterolemia who presented with statin and ezetimibe resistance. The patient received lipoprotein apheresis at 6 years of age. His low-density lipoprotein cholesterol levels signi
Externí odkaz:
https://doaj.org/article/b7166c23ef9341a7992157f19b11146a
Autor:
Hayato Tada, Nobuko Kojima, Yasuaki Takeji, Atsushi Nohara, Masa-aki Kawashiri, Masayuki Takamura
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100660- (2024)
Background: Achilles tendon thickening (ATT) can be ameliorated by lowering low-density lipoprotein (LDL) levels in patients with familial hypercholesterolemia (FH). The Japan Atherosclerosis Society (JAS) defines ATT as ≥8.0 mm in males and ≥7.5
Externí odkaz:
https://doaj.org/article/2a52166894b24ff89080ce8569d75c1d
Autor:
Hayato Tada, Atsushi Nohara, Soichiro Usui, Kenji Sakata, Masa-aki Kawashiri, Masayuki Takamura
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Risks of atherosclerotic events substantially vary even among patients with familial hypercholesterolemia (FH) with extremely high risk based on life-long exposure to high low-density lipoprotein cholesterol levels. This study aimed to exami
Externí odkaz:
https://doaj.org/article/d672726ab5834541af115e917e3b7dbb
Publikováno v:
Heliyon, Vol 10, Iss 8, Pp e29924- (2024)
Familial combined hypolipidemia, previously known as Familial hypobetalipoproteinemia 2 (FHBL2) is considered as an extremely rare recessive disease. Here, we present the case of familial combined hypolipidemia with homozygous loss-of function (LOF)
Externí odkaz:
https://doaj.org/article/c5cb395cb7fd444b82ad22d79ee550d1
Autor:
Kunimasa Yagi, Teruhiko Imamura, Hayato Tada, Jianhui Liu, Yukiko Miyamoto, Azusa Ohbatake, Naoko Ito, Masataka Shikata, Asako Enkaku, Akiko Takikawa, Hisae Honoki, Shiho Fujisaka, Daisuke Chujo, Hideki Origasa, Koichiro Kinugawa, Kazuyuki Tobe
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 6, Pp 1052-1061 (2022)
Abstract Aims/Introduction Diastolic cardiac dysfunction in type 2 diabetes (DD2D) is a critical risk of heart failure with preserved ejection fraction. However, there is no established biomarker to detect DD2D. We aimed to investigate the predictive
Externí odkaz:
https://doaj.org/article/6d8b372ab1a14724bd72e9b91811c6a3
Autor:
Hayato Tada, Nobuko Kojima, Kan Yamagami, Akihiro Nomura, Atsushi Nohara, Soichiro Usui, Kenji Sakata, Masayuki Takamura, Masa-aki Kawashiri
Publikováno v:
American Journal of Preventive Cardiology, Vol 12, Iss , Pp 100434- (2022)
Objective: The early diagnosis and treatment initiation for children with familial hypercholesterolemia (FH) has been recommended in guidelines. However, there is limited data on the impact of early treatments on the prognosis of children with FH. To
Externí odkaz:
https://doaj.org/article/77896a95d64b497cbd72c0f8b996cb25
Autor:
Hayato Tada, Nobuko Kojima, Kan Yamagami, Akihiro Nomura, Atsushi Nohara, Soichiro Usui, Kenji Sakata, Noboru Fujino, Masayuki Takamura, Masa-aki Kawashiri
Publikováno v:
American Journal of Preventive Cardiology, Vol 12, Iss , Pp 100428- (2022)
Objective: The synergistic effect of lipoprotein (a) [Lp(a)] and C-reactive protein (CRP) on major adverse cardiovascular events (MACE) among patients with familial hypercholesterolemia (FH) is unknown. This study aimed to investigate the relations b
Externí odkaz:
https://doaj.org/article/e2de0b1b331649ab847bea648e1c1347
Autor:
Yoshihiro Yamada, MD, PhD, Keiki Sugi, MD, PhD, Yodo Gatate, MD, Takaaki Senbonmatsu, MD, PhD, Ikuo Inoue, MD, PhD, Kenji Fukushima, MD, PhD, Atsushi Iguchi, MD, PhD, Hiroyuki Nakajima, MD, PhD, Toshihiro Muramatsu, MD, PhD, Shintaro Nakano, MD, PhD, Hayato Tada, MD, PhD
Publikováno v:
CJC Open, Vol 3, Iss 8, Pp 1085-1088 (2021)
Sitosterolemia is a rare, inherited, autosomal recessive disorder of lipid metabolism characterized by increased levels of plant sterols, such as sitosterol and campesterol, xanthomas, and accelerated atherosclerosis. In a 15-year-old boy exhibiting
Externí odkaz:
https://doaj.org/article/8ba94b95292049afa9eb7da754289ab8
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Type 1 familial hypobetalipoproteinemia (FHBL1), characterized by low levels of apolipoprotein B (ApoB)-containing lipoproteins, elevation of transaminases, and hepatic steatosis, is a rare disease the prevalence of which is 1 in 3,000 among general
Externí odkaz:
https://doaj.org/article/a13673965712490aba233fcc370e7a1a